HDA Testifies at House Hearing on Healthcare Affordability
February 11, 2026Today, HDA President and CEO Chester “Chip” Davis, Jr., testified before the House Energy and Commerce Health Subcommittee at a hearing on “Lowering Healthcare Costs: Examining the Healthcare Supply Chain.” In his testimony, Mr. Davis reaffirmed the critical role of distributors in the pharmaceutical supply chain and called on the subcommittee to explore the challenging reimbursement dynamics now facing providers.
“While we can agree that there is need for reform that benefits the patient and eases burdens on the provider, reforms should not come at the expense of the efficiency, security or reliability that exists in the pharmaceutical supply chain … Without security infrastructure and logistics capacity, accomplishing this would become challenging and costs would increase.
“Above all, we ask that [the subcommittee] examine the challenges that providers face being reimbursed at an appropriate level. For both physicians and pharmacists, the reimbursement dynamics are challenging and put their sustainability at risk. Without intervention, providers across the U.S. may suffer, increasing healthcare deserts and gaps in care.
“While distributors do not decide what is prescribed or what is dispensed, the list price of a medicine, or the price paid by a patient at the point of care, the core mission of a distributor is to ensure that whatever medicine is prescribed is available when and where it is needed. HDA and the distribution industry stand ready to continue to meet this challenge, recognizing the importance to the millions of Americans who depend on prescription medicines for their well-being every day.”
The full testimony is available here. To learn how distributors support access to safe and affordable pharmaceuticals, read HDA’s recent blog.
About HDA
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.